Publicaciones en colaboración con investigadores/as de Hospital General Universitario de Elche (46)

2021

  1. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer

    Genome Medicine, Vol. 13, Núm. 1

  2. Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses

    Gut, Vol. 70, Núm. 2, pp. 319-329

  3. Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study

    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), Vol. 30, Núm. 6, pp. 423-430

2020

  1. Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose-Response Relationships

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Vol. 29, Núm. 5, pp. 1009-1018

2019

  1. Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case–control approaches

    International Journal of Cancer, Vol. 144, Núm. 7, pp. 1540-1549

2018

  1. Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives

    International Journal of Epidemiology, Vol. 47, Núm. 2, pp. 473-483

2017

  1. Reduced risk of pancreatic cancer associated with asthma and nasal allergies

    Gut, Vol. 66, Núm. 2, pp. 314-322

2016

  1. Inflammatory-related genetic variants in non-muscle-invasive bladder cancer prognosis: A multimarker bayesian assessment

    Cancer Epidemiology Biomarkers and Prevention, Vol. 25, Núm. 7, pp. 1144-1150

  2. Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models

    BMC Cancer, Vol. 16, Núm. 1

2014

  1. Genetic variation in the TP53 pathway and bladder cancer risk. A comprehensive analysis

    PLoS ONE, Vol. 9, Núm. 5

  2. LINE-1 methylation in granulocyte DNA and trihalomethane exposure is associated with bladder cancer risk

    Epigenetics, Vol. 9, Núm. 11, pp. 1532-1539

  3. LINE-1 methylation in leukocyte DNA, interaction with phosphatidylethanolamine N-methyltransferase variants and bladder cancer risk

    British Journal of Cancer, Vol. 110, Núm. 8, pp. 2123-2130

  4. Whole genome prediction of bladder cancer risk with the bayesian LASSO

    Genetic Epidemiology, Vol. 38, Núm. 5, pp. 467-476

2013

  1. Application of multi-SNP approaches Bayesian LASSO and AUC-RF to detect main effects of inflammatory-gene variants associated with bladder cancer risk

    PLoS ONE, Vol. 8, Núm. 12

  2. Bladder cancer and seroreactivity to BK, JC and Merkel cell polyomaviruses: The Spanish bladder cancer study

    International Journal of Cancer, Vol. 133, Núm. 3, pp. 597-603

  3. Genetic and non-genetic predictors of LINE-1 methylation in leukocyte DNA

    Environmental Health Perspectives, Vol. 121, Núm. 6, pp. 650-656

2012

  1. Cyclooxygenase-2 Expression in Bladder Cancer and Patient Prognosis: Results from a Large Clinical Cohort and Meta-Analysis

    PLoS ONE, Vol. 7, Núm. 9

2011

  1. Socioeconomic status and exposure to disinfection by-products in drinking water in Spain

    Environmental Health: A Global Access Science Source, Vol. 10, Núm. 1

  2. Urinary pH, cigarette smoking and bladder cancer risk

    Carcinogenesis, Vol. 32, Núm. 6, pp. 843-847

2010

  1. Genetic Susceptibility to Distinct Bladder Cancer Subphenotypes

    European Urology, Vol. 57, Núm. 2, pp. 283-292